Table 5. Predictive values of rifampicin resistance in a hypothetic cohort of 1000 participants.

Index Test	3% Rifampicin Resistance				15% Rifampicin Resistance				30% Rifampicin Resistance
	PPV	NPV	FP	FN	PPV	NPV	FP	FN	PPV	NPV	FP	FN
	(95% CI)	(95% CI)			(95% CI)	(95% CI)			(95% CI)	(95% CI)
INNO LiPA	71.0%	99.8%	12	2	93.3%	99.0%	11	9	97.1	97.5%	9	18
	(31.1, 85.3)	(99.0, 99.9)			(72.0, 97.1)	(94.6, 99.6)			(86.2, 98.8)	(87.9, 98.9)
MTBDRplus	59.3%	99.9%	21	1	89.2%	99.3%	18	6	95.3%	98.3%	15	12
	(37.7, 69.5)	(99.7, 99.9)			(77.5, 92.9)	(98.3, 99.5)			(89.3, 96.9)	(95.9, 98.9)
MODS	79.8%	99.9%	8	1	95.8%	99.7%	7	3	98.2%	99.2%	5	6
	(35.5, 91.5)	(99.6, 99.9)			(75.9, 98.4)	(97.6, 99.9)			(88.4, 99.3)	(94.5 99.7)
NRA	93.0%	99.9%	2	1	98.7%	99.6%	2	3	99.5%	99.0%	1	7
	(73.0, 96.7)	(99.6, 99.9)			(93.9, 99.4)	(98.0, 99.8)			(97.4, 99.8)	(95.3, 99.6)
CRI	93.2%	99.9%	2	1	98.7%	99.8%	2	2	99.5%	99.5%	2	4
	(74.9, 96.8)	(99.8, 99.9)			(94.4, 99.4)	(99.2, 99.9)			(97.6, 99.8)	(98.1, 99.8)

CI= Confidence Interval PPV=positive predictive value, NPV=negative predictive value, FP= number of false positive index test results for a cohort of 1000 patients, FN= number of false negative index test results for a cohort of 1000 patient